昆明哪个医院看妇科最好(昆明一般流产手术要费用) (今日更新中)

The Food and Drug Administration approved on Wednesday a treatment for the Ebola virus. This is the first FDA-approved treatment for Zaire ebolavirus infection in adults and kids.Zaire ebolavirus is one of four Ebola virus species that can cause potentially deadly infections. It is transmitted through direct contact with blood, tissue or body fluids of an infected person or wild animal.The treatment, Inmazeb, is a mixture of three monoclonal antibodies and was created by Regeneron Pharmaceuticals. The three antibodies work together to bind to the glycoprotein on the surface of the Ebola virus and block it from entry into the body’s cells.Inmazeb was tested in the Democratic Republic of the Congo during an Ebola virus outbreak in 2018-2019 through a partnership between the local government and the National Institutes of Health.A vaccine for Ebola virus was approved by the FDA in December 2019.Regeneron is also the company behind an experimental antibody cocktail that was given to President Donald Trump following his diagnosis of COVID-19, and which he said “cured” him. Trump was also prescribed the antiviral drug remdesivir and the steroid dexamethasone at the time.Regeneron’s COVID-19 treatment is a mix of two powerful antibodies that are believed to boost the immune response to the coronavirus. Early results seem promising, according to initial tests and a press release from the company.The company has submitted an application to the FDA to get emergency approval of their COVID-19 treatment. 1525

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results.The 15-minute test from Abbott Laboratories will sell for , giving it a competitive edge over similar tests that need to be popped into a small machine. The size of a credit card, the self-contained test is based on the same technology used to test for the flu, strep throat and other infections.It’s the latest cheaper, simpler test to hit the U.S. market, providing new options to expand testing as schools and businesses struggle to reopen and flu season approaches. The FDA also recently greenlighted a saliva test from Yale University that bypasses some of the supplies that have led to testing bottlenecks.Both tests have limitations and neither can be done at home. Several companies are developing rapid, at-home tests, but none have yet won approval. Abbott’s new test still requires a nasal swab by a health worker, like most older coronavirus tests. The Yale saliva test eliminates the need for a swab, but can only be run at high-grade laboratories.And in general, rapid tests like Abbott’s are less accurate than lab-developed tests. The FDA said in a statement announcing the decision that negative results with Abbott’s test may need to be confirmed with a lab test in some cases. The agency granted Abbott’s test an emergency use authorization late Wednesday for patients with suspected COVID-19.The two additions should help expand the number of available tests. The U.S. is now testing about 690,000 people per day, down from a peak of 850,000 daily tests late last month. Many public health experts believe the country will soon need to test vastly more people to find those who are infected, isolate them and contain the virus.The FDA noted that Abbott’s test could be used in a doctor’s office, emergency room or some schools. “Given the simple nature of this test, it is likely that these tests could be made broadly available,” the FDA said.Since the start of the pandemic, nasal swab tests that are sent to a lab have been the standard for COVID-19 screening. While considered highly accurate, the tests rely on expensive, specialized machines and chemicals. Shortages of those supplies have led to repeated delays in reporting results, especially during a spike in cases last month.Government and health experts view rapid tests that can be run outside the laboratory system as key to boosting capacity.“Those screening tests are what we need in schools, workplaces and nursing homes in order to catch asymptomatic spreaders,” said Dr. Jonathan Quick of the Rockefeller Foundation, in an interview earlier this month. The nonprofit group has called for the U.S. to conduct about 4 millions per day by October, mostly rapid, point-of-care tests.Abbott’s BinaxNOW is the fourth rapid test that detects COVID-19 antigens, proteins found on the surface of the coronavirus, rather than the virus itself. It’s considered a faster, though sometimes less precise, screening method. The other tests need to be inserted into a small machine.Inside the Abbott test is a specially coated strip that interacts with COVID-19 antigens. The patient’s nasal swab is inserted into the card and a few drops of a chemical solution are added. Markings appear on the card to indicate whether the sample is positive or negative — much like a pregnancy test.Two other makers of antigen tests — Quidel and Becton Dickinson have said they haven’t been able to meet demand for the tests. A third, LumiraDx, plans to begin shipping its recently approved antigen tests by the end of this month. Abbott expects to begin shipping tests in September, reaching 50 million tests a month in October.The influx of antigen tests will go a long way toward meeting the Trump administration’s projection that 90 million COVID-19 tests a month will be available by September if needed. But U.S. “testing czar” Adm. Brett Giroir has stressed that the U.S. can contain the outbreak with far fewer tests.“That’s the capacity ... we do not need that many tests to safely and sensibly reopen,” Giroir told reporters on a recent call. He pointed to several key indicators that have been falling, including new infections and hospitalizations, even as testing has slowed.Earlier this month, the FDA authorized Yale’s saliva-based test, which is expected to cut the time and cost compared with similar tests. It’s the fifth COVID-19 saliva tests OK’d by regulators. All require lab processing.Developed by Yale’s School of Public Health, SalivaDirect can use any sterile container to collect a sample, not the special tube needed with earlier tests, and requires less chemicals. Outside experts welcomed the new approach but noted its limitations.“It’s not a rapid test, it’s a laboratory-based test that will still be prone to the same massive delays as any other test,” said Dr. Michael Mina of Harvard University.___Follow Matthew Perrone on Twitter: @ AP_FDAwriter.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5201

The Department of Defense announced on Friday the formation of the Unidentified Aerial Phenomena Task Force, which will be tasked with looking into reports of UFOs.The Pentagon says that task force’s mission is to detect, analyze and catalog unidentified aerial phenomena, better known as UFOs, that could potentially pose a threat to U.S. national security.“As DOD has stated previously, the safety of our personnel and the security of our operations are of paramount concern,” the Department of Defense said. “The Department of Defense and the military departments take any incursions by unauthorized aircraft into our training ranges or designated airspace very seriously and examine each report. This includes examinations of incursions that are initially reported as UAP when the observer cannot immediately identify what he or she is observing.”Sen. Marco Rubio confirmed the formation of the task force last month in an interview with Miami’s WFOR-TV."We have things flying over our military bases and places where we are conducting military exercises, and we don't know what it is and it isn't ours, so that's a legitimate question to ask,"Rubio said.In April, the Pentagon released videos of “unidentified aerial phenomena” captured by Navy pilots. One of the videos was from 2004, while another two were from 2015.“After a thorough review, the department has determined that the authorized release of these unclassified videos does not reveal any sensitive capabilities or systems, and does not impinge on any subsequent investigations of military air space incursions by unidentified aerial phenomena,” the Pentagon said in April. “DOD is releasing the videos in order to clear up any misconceptions by the public on whether or not the footage that has been circulating was real, or whether or not there is more to the videos.” 1846

The death of unarmed black men at the hands of police is not an issue often broached in the epicenter of the technology industry.But Ebele Okobi, Facebook's public policy director for Africa, hopes the death of her 36-year-old brother, Chinedu, can begin to change attitudes in the clubby and largely white world of Silicon Valley.The Morehouse College graduate died earlier this month after being tased during a confrontation with sheriff's deputies near San Francisco."It doesn't matter what school you went to," said Ebele Okobi, 44. "You can go to Harvard. You can work in tech. Every black American will tell you they live in a state of constant anxiety. Every black man will tell you they can work at Google, they can be a senior person at Facebook or Apple but when you're driving and you're a black man, you recognize the danger that you're in."The circumstances surrounding Okobi's death on the afternoon of October 3 remain unclear.The San Mateo County Sheriff's Office said deputies encountered Okobi "running in and out of traffic" on a street in Millbrae, a city about 30 miles northwest of Silicon Valley.Okobi "immediately assaulted" a deputy who got out of his vehicle, the statement said. There was a struggle with other deputies who responded.Okobi was taken into custody and transported to a hospital, where he died. A deputy was treated for injuries at a hospital, the sheriff's office said.Tasers were discharged at Okobi three to four times, according to San Mateo County District Attorney Stephen Wagstaff.One or more deputies fired Tasers. It's unclear how many times Okobi was struck, he said.An autopsy has been completed but investigators were awaiting toxicology reports, which could take four to six weeks, Wagstaff said.The district attorney's office, which investigates officer involved deaths, was still interviewing witnesses and combing through surveillance footage in the area, according to Wagstaff."We have hit a period of great concern regarding Tasers," said Wagstaff, adding that Okobi's death was the county's third since December during law enforcement encounters that involved the high-voltage stun guns.Wagstaff said it's still unclear if the Taser contributed to Okobi's death.The district attorney said his office will release video of the incident by mid-December.Ebele Okobi, whose family has retained an attorney, said prosecutors told her there was drone video of the encounter. She said the family's first contact with authorities was Wednesday.Prosecutors would not tell the family whether her brother can be seen assaulting a deputy in the video, she said.The sheriff's office said four deputies and a sergeant were involved in the incident. Deputies in "critical incidents where a death occurs are routinely placed on paid administrative leave, pending investigation," the office said."When the district attorney's office completes an investigation of sheriff's office staff, the San Mateo County Sheriff's Office will often conduct a separate administrative investigation in regards to compliance with our policies," the statement said.Chinedu Okobi graduated in 2003 with a degree in business administration from Morehouse College in Atlanta.He grew up in the San Francisco area as the youngest son of a Nigerian-American family, Ebele Okobi said.Chinedu Okobi, who has a 12-year-old daughter, spent the last decade struggling with mental health issues and may have stopped taking medications earlier this year, according to his sister."He was really gentle," Ebele Okobi recalled. "He was someone people connected to all his life. He was a kind person. He loved poetry. He recorded poetry. He recorded rap. He was also very spiritual and deeply religious."She marveled at the support from executives and others at Facebook."There definitely something insular about tech and definitely something insular about Silicon Valley," she said."But my colleagues at Facebook basically organized themselves and just kept telling the story and saying, this is important. Facebook's mission and Facebook's power to do good in the world -- that's the reason I work there. I've never seen this kind of solidarity and this kind of care."Ebele Okobi said that as a black woman she long feared losing a loved one in a violent police encounter.In 2014, after the birth of her son, she moved her family to London."I think it takes a huge amount of emotional courage to raise black children here and I knew that I didn't have it," she said. "I don't have the emotional fortitude to have a black husband and a black son in America. It's not as if I could take everyone I love with me."She said she hopes her brother's death resonates in Silicon Valley's corridors of influence and privilege."People who never thought this could happen to anybody they know, now know that it can," Ebele Okobi said."I hope this becomes a catalyst for more informed conversations" about police encounters with unarmed black men and the mentally ill as well as the use of Tasers on suspects. "My hope is that now that more people are proximate to these problems that they do something about them."A memorial fund to make donations to the Equal Justice Initiative?was set up in Chinedu Okobi's name. 5227

The Department of Homeland Security formally requested that the Pentagon extend the deployment of active-duty troops on the southern border Friday, potentially extending their deployment 45 days beyond the original deadline of December 15."Given the ongoing threat at our Southern border -- today the Department of Homeland Security submitted a request for assistance to the Department of Defense to extend its support through January 31, 2019," Department of Homeland Security spokeswoman Katie Waldman told CNN in a statement."This request refines support to ensure it remains aligned with the current situation, the nature of the mission, and (Customs and Border Protection) operational requirements," she added.The Pentagon confirmed receipt of the request but said Secretary of Defense James Mattis had yet to sign off on it:"We have received the Request for Assistance from the Department of Homeland Security, it is with the Secretary (of Defense) for consideration."There are currently some 5,600 troops at the border, divided among Texas, California and Arizona.President Donald Trump sent the troops after spending the weeks leading up to the midterm elections decrying a procession of migrants that was still thousands of miles from the US border. Last week, Trump granted the troops new powers to aid in "crowd control, temporary detention and cursory search" while protecting Customs and Border Protection personnel from the migrants, should they engage in violence.Defense officials have suggested that some of the troops, primarily engineers involved in enhancing infrastructure at points of entry, could be drawn down in the relative near term as those tasks are completed.Two officials tell CNN that the number of trumps assigned to the mission is likely to drop to 4,000 as a result.Other functions, including helicopter support to help move Customs and Border Protection personnel to different areas along the border, are likely to continue.The deployment's extension means the Pentagon's initial cost estimate of million for the border deployment is likely to increase as that estimate was based on the mission ending on December 15. 2175

来源：资阳报